May 16 (Reuters) – Pfizer Inc will buy Anacor
Pharmaceuticals Inc in a deal valued at $5.2 billion,
net of cash, for access to Anacor’s non-steroidal topical gel to
treat eczema.
The post Pfizer to buy Anacor Pharma in $5.2 bln deal appeared first on NASDAQ.